Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,371 | 36 | 82.3% |
| Consulting Fee | $295.00 | 1 | 17.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $339.14 | 11 | $0 (2024) |
| Dr.Reddy's Laboratories,Inc. | $295.00 | 1 | $0 (2017) |
| Allergan, Inc. | $287.26 | 5 | $0 (2022) |
| Galderma Laboratories, L.P. | $133.32 | 1 | $0 (2019) |
| Misonix Inc | $114.92 | 1 | $0 (2021) |
| Solta Medical, a division of Bausch Health US, LLC | $108.53 | 1 | $0 (2019) |
| Amgen Inc. | $84.45 | 1 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $62.35 | 3 | $0 (2022) |
| Sun Pharmaceutical Industries Inc. | $56.02 | 3 | $0 (2023) |
| Lilly USA, LLC | $49.15 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $87.76 | 4 | ABBVIE INC. ($65.85) |
| 2023 | $214.24 | 5 | ABBVIE INC. ($165.49) |
| 2022 | $107.05 | 5 | Regeneron Healthcare Solutions, Inc. ($25.42) |
| 2021 | $229.77 | 7 | Misonix Inc ($114.92) |
| 2020 | $118.77 | 7 | AbbVie Inc. ($61.88) |
| 2019 | $407.41 | 6 | Galderma Laboratories, L.P. ($133.32) |
| 2018 | $121.28 | 1 | Allergan Inc. ($121.28) |
| 2017 | $379.45 | 2 | Dr.Reddy's Laboratories,Inc. ($295.00) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | BioWound Solutions, Inc. | bio-ConneKt (Device) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Collagen wound matrix dressing | ||||||
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: IMMUNOLOGY | ||||||
| 06/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: IMMUNOLOGY | ||||||
| 09/28/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: IMMUNOLOGY | ||||||
| 04/17/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.50 | General |
| Category: IMMUNOLOGY | ||||||
| 04/13/2023 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: Dermatology | ||||||
| 03/03/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $23.11 | General |
| 02/11/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $142.17 | General |
| 07/01/2022 | Allergan, Inc. | — | Food and Beverage | In-kind items and services | $22.39 | General |
| 06/09/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: IMMUNOLOGY | ||||||
| 05/10/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.42 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/18/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: IMMUNOLOGY | ||||||
| 01/11/2022 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $18.64 | General |
| Category: Dermatology | ||||||
| 12/02/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Immunology | ||||||
| 11/19/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug), Absorica LD | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Dermatology | ||||||
| 10/28/2021 | Allergan, Inc. | — | Food and Beverage | In-kind items and services | $16.73 | General |
| 10/01/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/20/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: IMMUNOLOGY | ||||||
| 07/29/2021 | Misonix Inc | — | Food and Beverage | In-kind items and services | $114.92 | General |
| 07/21/2021 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Immunology | ||||||
| 09/26/2020 | DERMIRA, INC. | QBREXZA (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: DERMATOLOGY | ||||||
| 09/25/2020 | Sun Pharmaceutical Industries Inc. | ABSORICA LD (Drug) | Food and Beverage | Cash or cash equivalent | $14.52 | General |
| Category: Dermatology | ||||||
| 09/10/2020 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Immunology | ||||||
| 02/27/2020 | AbbVie Inc. | SKYRIZI (Biological), HUMIRA | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,367 | 1,990 | $850,260 | $366,622 |
| 2022 | 26 | 1,192 | 1,656 | $902,763 | $396,171 |
| 2021 | 19 | 611 | 752 | $446,481 | $204,779 |
| 2020 | 4 | 141 | 151 | $139,616 | $56,934 |
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 213 | 261 | $276,791 | $120,345 | 43.5% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 116 | 160 | $103,308 | $53,780 | 52.1% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 61 | 75 | $74,813 | $37,561 | 50.2% |
| 14061 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.1-30.0 sq cm | Office | 2023 | 27 | 29 | $44,725 | $23,376 | 52.3% |
| 14301 | Repair of wound by transferring skin, 30.1-60.0 sq cm | Office | 2023 | 22 | 22 | $36,879 | $19,297 | 52.3% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 86 | 89 | $65,588 | $17,580 | 26.8% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 67 | 76 | $50,633 | $14,294 | 28.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 84 | 102 | $19,978 | $9,359 | 46.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 69 | 69 | $17,572 | $8,385 | 47.7% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 41 | 44 | $20,977 | $8,209 | 39.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 83 | 125 | $17,327 | $7,961 | 45.9% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2023 | 16 | 24 | $14,850 | $7,777 | 52.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 59 | 67 | $10,738 | $4,800 | 44.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 94 | 125 | $13,131 | $4,666 | 35.5% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 19 | 20 | $12,491 | $4,231 | 33.9% |
| 13152 | Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm | Office | 2023 | 16 | 16 | $12,395 | $3,244 | 26.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 30 | 38 | $6,817 | $3,103 | 45.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 44 | 44 | $7,559 | $2,906 | 38.4% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 28 | 30 | $11,463 | $2,905 | 25.3% |
| 14302 | Repair of wound by transferring skin, each additional 30.0 sq cm | Office | 2023 | 11 | 15 | $4,869 | $2,545 | 52.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 74 | 406 | $4,295 | $2,150 | 50.0% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 13 | 14 | $6,932 | $1,815 | 26.2% |
| 29580 | Strapping, unna boot | Office | 2023 | 31 | 53 | $5,328 | $1,793 | 33.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 11 | 14 | $3,707 | $1,512 | 40.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 22 | 34 | $2,686 | $1,408 | 52.4% |
About Dr. Wayne Overman, M.D
Dr. Wayne Overman, M.D is a MOHS-Micrographic Surgery healthcare provider based in Arvada, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2014. The National Provider Identifier (NPI) number assigned to this provider is 1306258777.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wayne Overman, M.D has received a total of $1,666 in payments from pharmaceutical and medical device companies, with $87.76 received in 2024. These payments were reported across 37 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,371).
As a Medicare-enrolled provider, Overman has provided services to 3,311 Medicare beneficiaries, totaling 4,549 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Practice Information
- Specialty MOHS-Micrographic Surgery
- Location Arvada, CO
- Active Since 05/20/2014
- Last Updated 12/15/2020
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1306258777
Products in Payments
- BOTOX COSMETIC (Biological) $109.68
- SKYRIZI (Biological) $98.13
- DUPIXENT (Biological) $85.99
- Enbrel (Biological) $84.45
- RINVOQ (Biological) $56.88
- TALTZ (Drug) $49.15
- HUMIRA (Biological) $41.96
- Winlevi (Drug) $41.50
- bio-ConneKt (Device) $21.91
- OPZELURA (Drug) $18.64
- BOTOX (Biological) $17.18
- COSENTYX (Biological) $16.45
- ABSORICA LD (Drug) $14.52
- QBREXZA (Drug) $12.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.